TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06915246: A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Sponsor: VIVUS LLC · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 49 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$2,448,600

Rescue Site Savings

+$1,617,000

Unlock Full NCT06915246 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06915246 Rescue Dossier →